当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-04-11 , DOI: 10.1056/nejmoa2202170
Patrick M Forde 1 , Jonathan Spicer 1 , Shun Lu 1 , Mariano Provencio 1 , Tetsuya Mitsudomi 1 , Mark M Awad 1 , Enriqueta Felip 1 , Stephen R Broderick 1 , Julie R Brahmer 1 , Scott J Swanson 1 , Keith Kerr 1 , Changli Wang 1 , Tudor-Eliade Ciuleanu 1 , Gene B Saylors 1 , Fumihiro Tanaka 1 , Hiroyuki Ito 1 , Ke-Neng Chen 1 , Moishe Liberman 1 , Everett E Vokes 1 , Janis M Taube 1 , Cecile Dorange 1 , Junliang Cai 1 , Joseph Fiore 1 , Anthony Jarkowski 1 , David Balli 1 , Mark Sausen 1 , Dimple Pandya 1 , Christophe Y Calvet 1 , Nicolas Girard 1 ,
Affiliation  

New England Journal of Medicine, Ahead of Print.


中文翻译:


可切除肺癌的新辅助纳武单抗联合化疗



新英格兰医学杂志,印刷前。
更新日期:2022-04-11
down
wechat
bug